Who Owns Cardiff Oncology Stock?
NASDAQ: CRDFHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 22.12%
- Held by insiders
- 6.20%
- Institutional holders
- 129
- Institutions 22.1%
- Insiders 6.2%
- Public and other 71.7%
Who owns Cardiff Oncology stock?
Institutional investors own about 22.1% of Cardiff Oncology's shares, spread across 129 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 6.20% of CRDF.
The largest institutional holders are Laurion Capital Management, LP (3.98%), Vanguard Capital Management LLC (3.72%) and Pfizer Inc (3.10%). Together, the top 10 institutions control 18.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CRDF positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CRDF
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Laurion Capital Management, LP | 3.10M | 3.98% | +17.1% |
| Vanguard Capital Management LLC | 2.90M | 3.72% | +1.4% |
| Pfizer Inc | 2.41M | 3.10% | 0.0% |
| Franklin Resources, Inc. | 1.21M | 1.55% | 0.0% |
| Blackrock Inc. | 972.87K | 1.25% | -75.6% |
| BLAIR WILLIAM & CO/IL | 912.51K | 1.17% | -1.1% |
| Geode Capital Management, LLC | 820.06K | 1.05% | -48.7% |
| GoalVest Advisory, LLC | 687.28K | 0.88% | +100.0% |
| UBS Group AG | 638.70K | 0.82% | +59.5% |
| Jane Street Group, LLC | 607.90K | 0.78% | +1415.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CRDF
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.07M | 2.66% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 759.32K | 0.98% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 438.96K | 0.56% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 353.99K | 0.46% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 324.90K | 0.42% |
| iShares Trust-iShares Micro-Cap ETF | 220.23K | 0.28% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 114.05K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 100.74K | 0.13% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 72.06K | 0.09% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 46.24K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Cardiff Oncology?
Laurion Capital Management, LP is the largest institutional shareholder of CRDF, owning 3.98% of shares outstanding (3.10M shares) as of its latest 13F filing.
What percentage of Cardiff Oncology is owned by institutions?
Institutions own about 22.1% of CRDF shares and 23.6% of the public float.
How much of Cardiff Oncology do insiders own?
Insiders, such as officers and directors, own about 6.20% of CRDF shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.